Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4231 AL 4245

Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease

Ismaili L, do Carmo Carreiras M.

Curr Top Med Chem. 2017;17(31):3319-3327. doi: 10.2174/1568026618666180112155424.

New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines

Oset-Gasque MJ, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3349-3360. doi: 10.2174/1568026618666180112155928.

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

Romero A, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3328-3335. doi: 10.2174/1568026618666180112155639.

Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics

Chakraborty S.

Curr Top Med Chem. 2017;17(31):3336-3348. doi: 10.2174/1568026618666180116122921.

Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5

Brody AH, Strittmatter SM.

Adv Pharmacol. 2018;82:293-323. doi: 10.1016/bs.apha.2017.09.007. Epub 2017 Oct 25.

New Insights Into Autophagy Dysfunction Related to Amyloid Beta Toxicity and Neuropathology in Alzheimer's Disease

Ntsapi C, Lumkwana D, Swart C, du Toit A, Loos B.

Int Rev Cell Mol Biol. 2018;336:321-361. doi: 10.1016/bs.ircmb.2017.07.002. Epub 2017 Sep 6.

Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry

Garcia-Ptacek S, Modéer IN, Kåreholt I, Fereshtehnejad SM, Farahmand B, Religa D, Eriksdotter M.

Age Ageing. 2017 Mar 1;46(2):314-319. doi: 10.1093/ageing/afw189.

A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland

Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D.

Drugs Aging. 2017 Jan;34(1):55-65. doi: 10.1007/s40266-016-0419-5.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D.

Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012.

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial

Campbell NL, Perkins AJ, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA.

J Am Geriatr Soc. 2017 Jul;65(7):1497-1504. doi: 10.1111/jgs.14827. Epub 2017 Mar 14.

A Black Alzheimer's Patient Wants To Be Part Of The Cure

Gray K.

Health Aff (Millwood). 2017 Jun 1;36(6):1129-1132. doi: 10.1377/hlthaff.2017.0296.

Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion

Twyman RE.

Neurochem Res. 2017 Jul;42(7):2099-2115. doi: 10.1007/s11064-017-2300-2. Epub 2017 Jun 7.

DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review

Chalichem NSS, Gonugunta C, Krishnamurthy PT, Duraiswamy B.

Am J Alzheimers Dis Other Demen. 2017 Nov;32(7):444-451. doi: 10.1177/1533317517722005. Epub 2017 Jul 27.

Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients

Vakilian A, Razavi-Nasab SM, Ravari A, Mirzaei T, Moghadam-Ahmadi A, Jalali N, Bahramabadi R, Rezayati M, Yazdanpanah-Ravari A, Bahmaniar F, Bagheri MR, Sheikh Fathollahi M, Asadikaram G, Kazemi Arababadi M.

Neuroimmunomodulation. 2017;24(6):310-319. doi: 10.1159/000486597. Epub 2018 Mar 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias